---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008854"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T14:20:52.067827+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharma stockholders approve reverse stock split up to 1-for-250 at special meeting

## Summary
- Proposal passed with 5,065,868 votes for, 496,473 against, 1,438 abstentions.
- Board may implement split at ratios from 1-for-2 to 1-for-100, aggregate not exceeding 1-for-250.
- The reverse stock split amendments to the certificate of incorporation have been authorized.
- Company's common stock trades under CDT on Nasdaq; warrants trade under CDTTW.

## SEC filing metadata
- accession: 0001641172-25-008854
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/0001641172-25-008854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008854
- JSON: https://secwatch.observer/filing/0001641172-25-008854.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008854.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.